Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study

References

• DongFXuTShenYDysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedureOncotarget2017816275472756828187437
   PubMedGoogle Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• PruthiRSBaldwinNBhalaniVWallenEMConservative management of low risk superficial bladder tumorsJ Urol200817918790 discussion 9017997444
   PubMed Web of Science ®Google Scholar
• WitjesJACompératECowanNCMuscle-invasive and metastatic bladder cancerEAU- ESTRO-ESUR-SIOG GuidelinesArnhemEAU Guidelines Office2017910
   Google Scholar
• RosenbergJECarrollPRSmallEJUpdate on chemotherapy for advanced bladder cancerJ Urol20051741142015947569
   PubMed Web of Science ®Google Scholar
• BianchiMRoghmannFBeckerAAge-stratified distribution of metastatic sites in bladder cancer: a population-based analysisCan Urol Assoc J201483–4E148E15824678354
   PubMed Web of Science ®Google Scholar
• PatelVCollazo LorduyASternASurvival after metastasectomy for metastatic urothelial carcinoma: a systematic review and meta-analysisBladder Cancer20173212113228516157
   PubMed Web of Science ®Google Scholar
• ChenCHuLChenYHouJThe prognostic value of histological subtype in patients with metastatic bladder cancerOncotarget2017817284082841728415699
   PubMedGoogle Scholar
• TaguchiSNakagawaTUemuraYValidation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real worldWorld J Urol201634216317126135306
   PubMed Web of Science ®Google Scholar
• AbeTKitamuraHObaraWOutcome of metastasectomy for urothelial carcinoma: a multi-institutional retrospective study in JapanJ Urol2014191493293624211599
   PubMed Web of Science ®Google Scholar
• PondGRAgarwalNBellmuntJA nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinomaBJU Int20141135bE137E14324219029
   PubMed Web of Science ®Google Scholar
• von der MaaseHSengelovLRobertsJTLong-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancerJ Clin Oncol200523214602460816034041
   PubMed Web of Science ®Google Scholar
• SternbergCNVogelzangNJGemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancersCrit Rev Oncol Hematol200346SupplS105S11512850531
   PubMed Web of Science ®Google Scholar
• KimTAhnJHYouDPulmonary metastasectomy could prolong overall survival in select cases of metastatic urinary tract cancerClin Genitourin Cancer2015134e297e30426007709
   PubMed Web of Science ®Google Scholar
• MatsugumaHYoshinoIItoHIs there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma?Ann Thorac Surg201192244945321801905
   PubMed Web of Science ®Google Scholar
• CowlesRSJohnsonDEMcMurtreyMJLong-term results following thoracotomy for metastatic bladder cancerUrology19822043903927147508
   PubMed Web of Science ®Google Scholar
• OttoTKregeSSuhrJRubbenHImpact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trialUrology2001571555911164143
   PubMed Web of Science ®Google Scholar
• LehmannJSuttmannHAlbersPSurgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05)Eur Urol20095561293129919058907
   PubMed Web of Science ®Google Scholar
• AndersonRSel-MahdiAMKubanDAHigginsEMBrain metastases from transitional cell carcinoma of urinary bladderUrology199239117201728790
   PubMed Web of Science ®Google Scholar
• Mahmoud-AhmedASSuhJHKupelianPABrain metastases from bladder carcinoma: presentation, treatment and survivalJ Urol200216762419242211992049
   PubMed Web of Science ®Google Scholar
• Siefker-RadtkeAOWalshGLPistersLLIs there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experienceJ Urol2004171114514814665863
   PubMed Web of Science ®Google Scholar
• FokasEHenzelMEngenhart-CabillicRA comparison of radiotherapy with radiotherapy plus surgery for brain metastases from urinary bladder cancer: analysis of 62 patientsStrahlenther Onkol20101861056557121107928
   PubMed Web of Science ®Google Scholar
• KanzakiRHigashiyamaMFujiwaraAOutcome of surgical resection of pulmonary metastasis from urinary tract transitional cell carcinomaInteract Cardiovasc Thorac Surg2010111606420395251
   PubMed Web of Science ®Google Scholar
• MatsugumaHYoshinoIItoHMetastatic Lung Tumor Study Group of JapanIs there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma?Ann Thorac Surg201192244945321801905
   PubMed Web of Science ®Google Scholar
• BekkuKSaikaTKobayashiYCould salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?Int J Clin Oncol201318111011522095246
   PubMed Web of Science ®Google Scholar
• SweeneyPMillikanRDonatMIs there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?J Urol200316962113211712771730
   PubMed Web of Science ®Google Scholar
• NecchiAGiannatempoPLo VulloSPostchemotherapy lymphadenectomy in patients with metastatic urothelial carcinoma: long-term efficacy and implications for trial designClin Genitourin Cancer20151318086.e125027186
   PubMed Web of Science ®Google Scholar
• WuSGLiHTangLYThe effect of distant metastases sites on survival in de novo stage-IV breast cancer: a SEER database analysisTumour Biol2017396 1010428317705082
   Google Scholar
• OweiraHPetrauschUHelblingDPrognostic value of site-specific metastases in pancreatic adenocarcinoma: a surveillance epidemiology and end results database analysisWorld J Gastroenterol201723101872188028348494
   PubMed Web of Science ®Google Scholar
• BellmuntJChoueiriTKFougerayRPrognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimensJ Clin Oncol201028111850185520231682
   PubMed Web of Science ®Google Scholar
• SonpavdeGPondGRFougerayRTime from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trialsEur Urol201363471772323206856
   PubMed Web of Science ®Google Scholar
• NakagawaTHaraTKawaharaTPrognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomyJ Urol201318941275128123123368
   PubMed Web of Science ®Google Scholar
• HerrHWDonatSMBajorinDFPost-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancerJ Urol2001165381181411176475
   PubMed Web of Science ®Google Scholar
• GandagliaGFossatiNStabileARadical prostatectomy in men with oligometastatic prostate cancer: results of a single-institution series with long-term follow-upEur Urol201772228929227574820
   PubMed Web of Science ®Google Scholar
• SantambrogioROpocherECostaMBrunoSCerettiAPSpinaGPNatural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the pastWorld J Gastroenterol200612396331633817072957
   PubMed Web of Science ®Google Scholar